Radiopharmaceutical Trials

Radiopharm Theranostics preps RAD 402 for first-in-human trials in prostate cancer

Radiopharm Theranostics bereitet RAD 402 für erste Studien am Menschen bei Prostatakrebs vor.

Telix Pharmaceuticals gains from CMS new regulation on diagnostic radiopharmaceutical payments

Bicycle Therapeutics reveals breakthrough cancer imaging data

BioCryst initiates Phase 1 trial enrolment for Netherton syndrome therapy

Ascendis Pharma's TransCon CNP shines in ApproaCH trial results

Clarity Pharmaceuticals reports SECuRE trial results